ArticleJHEP reports : innovation in hepatology2026

Genome-scale CRISPR screening uncovers SRSF6 as a target to sensitize hepatocellular carcinoma to radiotherapy.

Wenyi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.